Wednesday 4 December 2019
Tuesday 3 December 2019
Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $LHS.C) (OTCQX: $LHSIF) (OTCQX: $MRMD) (TSX: $FAF.TO)
Investor
Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (CSE: $LHS.C) (OTCQX: $LHSIF)
(OTCQX: $MRMD) (TSX: $FAF.TO)
Delta, Kelowna, BC, December 3, 2019 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast
edition of cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/12031LHS-LHSIF-MRMD-FAF.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In today’s podcast
we look at a few early announcements.
But first, Shoppers
Drug Mart has expanded its online platform for the sale of medical cannabis to
include British Columbia, Nova Scotia, Manitoba, Saskatchewan, New Brunswick, P.E.I., Newfoundland and Labrador. The service breaks down existing barriers
for patients by providing convenient access to a broader range of options
through a single source, alongside expert advice and counsel from trusted
healthcare professionals.
According
to Statistics Canada, over 1.1 million Canadians use cannabis for medical
purposes, but more than 800,000 patients are self-medicating with recreational
or illegal cannabis without the guidance of a healthcare professional.i
In British Columbia, 18,326 people obtain their medical cannabis through the
legal system, but the patient population is likely much larger.ii The high rate of self-medicating is
concerning as a 2019 survey found that 76 per cent of medical cannabis patients
wrongly believe there are no side effects from combining cannabis with other
medications.iii
"Canadians
continue to use cannabis for medical purposes but many have been left behind by
traditional models. Patients need more convenient access to their medicine with
professional oversight and trusted support," said Jeff Leger, President,
Shoppers Drug Mart. "We expanded Medical Cannabis by Shoppers™ nationally
to provide enhanced service to more patients so they can feel empowered to
access medical cannabis through the medical market with the guidance of
healthcare professionals."
First launched in
Ontario in January 2019 and then in Alberta in April 2019, Medical Cannabis by
Shoppers™ provides patients access to a number of products from Canadian
licensed producers, shipped directly and discreetly to their doorstep.
Additionally, support is available for patients through the Shoppers cannabis
care centre – a call center staffed by professionals who offer counselling and
support for patients. Under current regulations, pharmacists cannot dispense
medical cannabis from a pharmacy.
Patients in British
Columbia can now obtain their medical document (authorization from a health
care practitioner) directly from shoppersdrugmart.ca/cannabis
or bring it to their local Shoppers Drug Mart pharmacy to help process the
information. Specialized advisors from
the Shoppers cannabis care centre will then contact patients, review their
medical history and any contraindications with current medications, and provide
support with online registration and strain selection.
Education for
pharmacists is supported by the Shoppers Drug Mart Medical Advisory Board, a
panel of independent medical experts from across the country who provide
guidance and advice on new clinical evidence, and have developed clinical
algorithms to help the Shoppers cannabis care Advisors select the correct
strain based on the prescriber's recommendation.
For patients who do
not have access to a healthcare practitioner, Shoppers can connect patients to
a licensed physician or nurse practitioner to assess whether a patient is an
ideal candidate for medical cannabis.
Shoppers can connect patients to healthcare practitioners through an
online telemedicine portal or patients can use the Shoppers Clinic Finder at https://cannabis.shoppersdrugmart.ca/medical-document-info
Liberty
Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) announced today that it is expanding its product offerings
by introducing the G Pen product line of personal, portable devices in all of
its dispensaries. G Pen products will be available with Liberty's unique Werc
Shop terpene blend.
Grenco Science, the
maker of the G Pen Gio, Pro, Connect, Elite and Nova, is a leader in
engineering advanced cannabis vaporizers, known for its aesthetics,
portability, functionality, and user experience. Grenco Science launched the G
Pen in 2012 and was one of the first vaporizer companies to develop a portable
device for cannabis concentrates. The G
Pen's sleek design and ease of use make it a popular choice among consumers.
"In
relationship to our ongoing transformation, Liberty is excited to introduce G
Pen's line of world class cannabis vaporizers to our patients who have grown to
trust and love the access we offer to the best brands in any category,"
said Victor Mancebo, Interim Chief Executive Officer of Liberty. "Grenco
Science has set the standard for excellence with their user-friendly portable
vaporizers."
Chris Folkerts,
Founder and CEO Grenco Science said, "Grenco Science is pleased to
announce its partnership with Liberty Health Sciences, a leader in Florida's
vertically integrated market. We look forward to bringing the G Pen product
line to all of Liberty's stores and offering greater accessibility to Florida's
medical cannabis consumers."
Liberty's product
offerings include eight outstanding quality brands including Liberty Health
Sciences, Zentient, Pretty Pistil, Papa's Herb, Mary's Medicinal, PAX, Werc
Shop, Lemon and Grass, and is currently working on rolling out nine additional
brands, subject to Florida Department of Health approval.
Avicanna
Inc. (TSX: AVCN) (OTCQX: AVCNF), a biopharmaceutical company focused on
the development, manufacturing and commercialization of organic and sustainable
plant-derived cannabinoid-based products, announced that the Company has entered into an
importation and distribution agreement with Astral Health Ltd., the operating
subsidiary of the LYPHE Group Ltd to supply its cannabis-based medicinal
products to patients in the United Kingdom under the MHRA 'specials' programme.
"We look
forward to the opportunity to provide access to our cannabis-based medicinal
formulations to a population and medical community that is seeing increased
demand for quality evidence-based products, such as our proprietary
research-backed formulations. Both the Astral and Avicanna teams are aligned on
the long-term vision and more importantly are qualified to provide the medical community
in the United Kingdom with safe, effective and superior cannabinoid-based
solutions, education and training," stated Aras Azadian, Chief Executive
Officer.
Dean Friday, Chief
Executive Officer of LYPHE, commented "We are very proud to be partnering
with Avicanna in bringing their products to the UK market. Avicanna are market-leaders in terms of
product quality, and their research-backed formulations give the company a
distinct advantage in the UK market".
Under the
Agreement, Avicanna will supply Astral with CBMPs, and both Avicanna and Astral
will work together to achieve key strategic milestones in the United Kingdom
related to market activation, market access and safety. The parties will also
work together to collaborate on medical education programs with a focus on
safety, dose guidance and efficacy. The Agreement will allow Avicanna to begin
generating revenue from a growing UK market, while providing patients with
increased access to the life-changing medicines they require.
It is expected that
the CBMPs will be prepared in Colombia using Avicanna's proprietary
research-backed formulations, using cannabis extracts from Santa Marta Golden
Hemp S.A.S., a subsidiary of Avicanna, and manufactured at the facilities of
Avicanna's exclusive Colombian manufacturer, Altea Farmaceutica S.A. using Good
Manufacturing Practices (GMP).
MariMed
Inc. (OTCQX: MRMD), a leading multi-state cannabis and hemp
operator focused on health and wellness, today announced that its proprietary, in-house brand,
Betty's Eddies™, is among the top-selling sublingual and edible products
in a national survey conducted by LeafLink, the leading wholesale platform for
cannabis products in the United States.
On November 19,
LeafLink released its second-annual LeafLink List, honoring the standout cannabis
brands, products, and retailers on its B2B e-commerce marketplace, which
processes over $1.4B per year in wholesale cannabis orders. Over 1100 brands
were included in the survey. MariMed, Inc. in-house brand Betty's Eddies™,
which are gluten-free, vegan, and produced with organically grown fruits and
veggies, is the LeafLink Winner for Best Selling Medical Product.
MariMed's family of
brands sell in the dispensaries it owns and manages, and on a wholesale basis
to retailers in each of the six states it operates. Several recent marketing
studies have concluded that infused cannabis products will occupy an increasing
share of the overall US cannabis market, which according to the 2019 Marijuana
Fact Book, is on pace to exceed 35% growth and $12 billion in sales this year.
Betty's is the most
widely distributed product in Maryland, reaching over 70 state dispensaries in
less than ten months. New SKUs, including Extra Strength Betty's Eddies™, will
launch in Maryland, Rhode Island, Illinois, and Massachusetts in December of
2019.
Ryan Crandall,
Chief Product Officer and SVP of Sales at MariMed, Inc., said, "I am
thrilled cannabis consumers love the Betty's Eddies brand and products as much
as our hardworking team, which is responsible for their quality, custom
formulation, and wide availability. Betty's will continue to innovate with new
seasonal flavors, limited release small-batch drops, and delicious new Betty's
products. The expertise to consistently shape the intended product experience
in any state or territory is most important to building consumer trust, brand
loyalty, and ultimately revenue growth."
The Branded Product
Division at MariMed recently launched Betty's Eddies™ in Rhode Island and plans
to launch in MA and Puerto Rico in the next 60 days. MariMed will be opening
its Panacea Wellness facility in Massachusetts in mid-December for medical
cannabis patients, and recently completed the consolidation of its two managed
dispensaries in Illinois.
Bob Fireman, CEO of
MariMed, Inc., said, "We are pleased to see the strength of our brands
recognized for their significant acceptance and sales growth across multiple
markets. Our product division is both innovative and highly responsive to
tastes, patient needs, and trends that differ from market to market. As our
quality manufacturing capacity and licensing relationships grow, we anticipate
MariMed's product family to continue to prosper in a crowded market."
Fire
& Flower Holdings Corp. (TSX: FAF), will release its financial and operational results for
the third quarter ended November 2, 2019 before financial markets open on
December 17, 2019.
Fire & Flower's
third quarter fiscal 2019 financial and operational results will be available
on SEDAR and on the Company's website at https://fireandflower.com/investor-relations.
Following the
release of its third quarter fiscal 2019 financial and operational results,
Fire & Flower will host a conference call and webcast with Trevor Fencott,
Chief Executive Officer at 8:30 AM Eastern Time on December 17, 2019.
Investor ideas
reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com
website and this podcast is not an endorsement to buy products or services or
securities. Investors are reminded all investment involves risk and possible
loss of investment
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
#CannabisStocks: Jetblack Corp (OTC: $JTBK) Details EndoCleanse™ Benefits for Cannabis Users @jetblackcorp
#CannabisStocks:
Jetblack Corp (OTC: $JTBK) Details EndoCleanse™
Benefits for Cannabis Users @jetblackcorp
Portland, OR – December 3, 2019 –
(Investorideas.com Newswire) Jetblack Corp. (OTCMKTS:
JTBK) “the company” “JTBK” provided more
details on EndoCleanse™ a “first of its kind” product in formulation.
EndoCleanse™ is a product that will
give the daily consumer of cannabis, the ability to feel like they have taken a
break from consuming cannabis, flushing the receptors (CB1 and CB2), which will
make the intake of marijuana and its desired effects more efficient.
Additional benefits of EndoCleanse™
would be, saving a consumer time and money. Taking away the need to constantly
seek out different strains, along with consuming less marijuana in general.
Read this in
full at https://www.investorideas.com/news/2019/cannabis/12032Jetblack-EndoCleanse.asp
The company believes that regular
daily consumers of marijuana will benefit greatly from this product. Daily
consumers often need to seek out different strains to feel a strong effect or
seek out concentrates.
Statistics have shown upwards of 10%
of the adult population in the US consume marijuana daily. Roughly another 10%
consume weekly. “This is a huge market with lots of untapped potential, even
amongst daily users, not to mention the weekly consumers,” explained Jetblack
Corp. CEO.
The recent identification of
cannabinoid receptors, CB1 and CB2 receptors has started an exponential growth
of studies exploring the endocannabinoid system and its regulatory functions
concerning health and disease.
The endocannabinoid system is still
being studied, and research is in its infancy. The company believes this
product may also benefit non-cannabis users as well, as we know now the
endocannabinoid system plays an important role in our health. “This is why we have stated from the
start, EndoCleanse™ is a wellness product,” explained the CEO.
About
Jetblack Corp.
Jetblack Corp. (OTCMKTS: JTBK) is a
company focused on commercializing innovative ideas for the benefit of
shareholders and the community. The focus of the company is to spend a small
amount of capital on each innovative product, with the potential to benefit
society and or the environment. Distributing risk across a variety of products
and sectors, reducing the risk for shareholders while enhancing the chance for
success. The company also gives the investor the ability to put their capital
to work for a good cause. We are continually identifying how we can make an impact
for the better.
Why
us and what makes us unique?
We plan to provide an opportunity for
investors to put their capital to work in a beneficial way for society.
Products that may make an impact to improve lives and/or the
environment. Opportunity for conscious investing.
More
information about JTBK can be found at:
Disclaimer:
This press release contains forward-looking
statements. All statements other than statements of historical facts included
in this press release are forward-looking statements. In some cases, forward-
looking statements can be identified by words such as "believe,"
"expect," "anticipate," "plan,"
"potential," "continue" or similar expressions. Such
forward-looking statements include risks and uncertainties, and there are
important factors that could cause actual results to differ materially from those
expressed or implied by such forward-looking statements. These factors, risks
and uncertainties include market risks associated with our business, the
inability to raise enough capital to complete our business, economic conditions
and increasing competition. Investors should not place any undue reliance on
forward-looking statements since they involve known and unknown, uncertainties
and other factors which are, in some cases, beyond the Company's and
management’s control which could, and likely will, materially affect actual
results, levels of activity, performance or achievements. Investors should be
cautioned that nine out of ten start-ups and small businesses fail. If the
company cannot achieve financing, then it may not be able to follow through
with its business plan. This may lead to an investor losing part or their
entire investment. Investors may have trouble locating a broker dealer to trade
their stock. Any forward-looking statement reflects the Company's current views
with respect to future events and is subject to these and other risks,
uncertainties and assumptions relating to operations, results of operations,
growth strategy and liquidity. The Company assumes no obligation to publicly
update or revise these forward-looking statements for any reason, or to update
the reasons actual results could differ materially from those anticipated in
these forward-looking statements, even if new information becomes available in
the future. The loss of key employees would be detrimental to the company
success and may cause failure. Currently the company is considered a penny
stock, which means the spreads can be very far apart, sometimes illiquid, and
investors may not be able to sell when they want or for the price they paid. In
some circumstances the investor may lose all their investment.
Source: Jetblack Corp.
Contact:
Corporate Communication
Jetblack Corp. IR Department
1-888-611-5825
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure: This news release featuring JTBK is a paid for news
release on Investorideas.com ($450 Special) More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories
#Cannabis #Stock News -American Premium Water Corp.'s (OTC: $HIPH) plant + body essentials #CBD Topicals for Sale Online; @AmericanPremium
#Cannabis #Stock News -American Premium Water Corp.'s (OTC: $HIPH) plant + body essentials #CBD Topicals for Sale Online; @AmericanPremium
American Premium Water CBD brand is now available for sale on its website; discussions ongoing for retail distribution
PLAYA VISTA, CA - December 3, 2019 (investorideas.com Newswire) CBD company news - American Premium Water Corporation’s (OTC: HIPH) (“the Company”) plant + body essentials brand is now available for sale at its e-commerce site (www.plantbodyessentials.com) in advance of the Black Friday – Cyber Monday holiday period. The Company acquired the brand earlier in 2019, and will launch sales with four products – three complimentary CBD-infused topical balms and one CBD-infused lip balm. The Company is also in discussions with retailers and distributors to sell the brand in stores.
Read this in full at https://www.investorideas.com/news/2019/cannabis/12031OTCHIPH-PlantBodyEssentials.asp
American Premium Water Corporation CEO Ryan Fishoff stated, “I am pleased to announce that plant + body essentials e-commerce store is live and is ready, just in time for the holiday shopping season. This is another step towards generating revenue for the Company and monetizing the Company’s assets. The plant + body product is exceptional and is priced competitively with comparable products. The CBD topicals segment of the market is attractive as big box retailers have embraced this product category. This a growing segment of the market that has no clear market front runners; we feel there is a significant potential in this space for growth and opportunity. The Company is working hard to expand distribution for plant + body outside its e-commerce site. I invite shareholders to go to our site and test the samples. Everyone keep their eyes open; there will be investor specials throughout the holiday season.
“Expanding distribution for the Company’s portfolio of brands and products is our number one priority. Diversifying our product mix will allow us to capitalize off the demand in CBD products from big box retailers. As I’ve previously discussed, big box retailers have had some hesitation carrying CBD-infused ingestibles because of the lack of clarity from the FDA. Cosmetics have been more widely accepted, as CVS, Walgreens, Krogers, and other large chains have begun to stock CBD topical products. Certainly we will be targeting these chains among others for retail distribution for plant + body and our other topical brands. The Company is also actively working on expanding distribution of LALPINA CBD Water; we recently added 7-Eleven as a distribution channel. The initial results have been quite positive as that store sold out its initial order and was re-stocked last weekend. We are in discussions to add more stores. In addition we are working on developing more products in the beverage category that will open sales in more stores. The Company is also actively seeking opportunities to grow revenue through acquisitions and partnerships that align with our business plan. The Company is poised to close the year strong and I look forward to keeping shareholders updated as milestones are achieved,” concluded Mr. Fishoff.
LALPINA CBD water can be purchased online at: https://www.singleseed.com/product/lalpina-cbd-water-6-pack/
LYNKS Pet CBD Water can be purchased online at: https://www.singleseed.com/product/lynks-cbd-pet-water-6-pack/
Vanexxe can be purchased on Amazon here.
The Company’s research report was recently updated by Ludlow Research with a short-term price target of $0.03. To read full report, risks, and disclosures, click here.
About American Premium Water Corp.
American Premium Water (HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of Nano technologies paired without cannabidiol (CBD) to treat health disorders and enhance quality of life. The company’s portfolio includes the LALPINA Hydro and LALPINA CBD brands (www.lalpinahydrocbd.com), Gents (www.gentsco.com), Vanexxe (www.vanexxe.com) and plant + body essentials (www.plantbodyessentials.com).
American Premium Water strives in providing only the highest quality CBD sources for its products, with quality control being one of our first and foremost focuses. The Company aims for this standard not only for compliance reasons, but also to provide our customers the highest quality product possible.
Safe Harbor Notice
Certain statements contained herein are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). American Premium Water Corporation cautions that statements made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates and assumptions made by management. Actual results could differ materially from current projections or implied results. American Premium Water Corporation undertakes no obligation to revise these statements following the date of this news release. Additional details of the Company's business can be found in its public disclosures as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
This press release is issued on behalf of the Board of Directors of American Premium Water Corporation.
Investor Relations
888-983-0054
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. This news release featuring HIPH is a paid for news release on Investorideas.com More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about pricing and publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Monday 2 December 2019
Subscribe to:
Posts (Atom)
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T... -
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...